Quote from tomgordon:
so they borrowed money to pay out this monster dividend?
why would they do this?
i have never seen anything like it
but the stock is cookin today
so maybe they know something i dont
Quote from Casey30:
Special dividends are infrequent, however companies often issue debt to pay it out. It really isn't that rare. Also, after about 30 minutes or maybe a day, the shares factor in the special div.The money that could have been made is if you bought on the initial release of the news as quickly as possible.
Quote from arickwon:
CEO owns 2.9 million shares why not get a pay day? he'll make almost 20 mil from dividends, at the expense of the company of course. Got to love capitalism, ppl will do anything for money.
The company amended its senior secured credit facilities to borrow an additional $1.5 billion in term loans.
Also Friday, it closed on its $750 million offering of 7.75 percent senior notes due 2018.
The dividend, payable to shareholders of record as of Aug. 30, will be paid on Sept 8.
The cost of the dividend is about $2.14 billion.
Quote from gimp570:
anyone with half a brain that can tell me what this means??
i must be to much of a dummy to understand
ARDEE, Ireland, Aug. 24 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq:WCRX - News) today announced that it has received the Food and Drug Administration's ("FDA's") response to a citizen petition it had filed regarding its ASACOL and ASACOL HD products. In its petition, Warner Chilcott requested that the FDA (1) issue bioequivalence guidance for mesalamine delayed-release tablets, (2) not approve any abbreviated new drug applications ("ANDAs") referencing ASACOL and/or ASACOL HD unless the proposed generic product is shown to be bioequivalent based on appropriate data from a clinical efficacy endpoint study, comparative pharmacokinetic testing and rigorous in vitro dissolution testing and (3) deny any waiver of bioequivalence testing for either ASACOL or ASACOL HD based on a showing of bioequivalence in the other strength. In its joint-response to the citizen petitions of the Company and another petitioner, the FDA has granted in part and denied in part various aspects of the citizen petitions. The impact of the FDA's response will depend upon the particular facts of any ANDA filed referencing ASACOL and/or ASACOL HD.
A copy of the FDA's response letter is available in the Investor Relations section of the Company's website at www.wcrx.com. In addition, the Company's citizen petition and related information and the FDA's response letter are, or will be made available, on the www.regulations.gov website.
Quote from gimp570:
based on the price action today i guess it is so so news. WCRX is up and the market is in the toilet.
it sounds like some stuff was approved and some stuff was not...and until we know the details..which i would love to know the time frame for ....WCRX seems like a huge risk/huge reward stock...
could got threw the roof any second or could take a crap any time